about
Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasisTNF-α gene polymorphisms and expressionAssembly of inflammation-related genes for pathway-focused genetic analysisAltered bone remodeling in psoriatic arthritisGenetics of psoriasis and psoriatic arthritis.Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.Single nucleotide polymorphisms in the tumor necrosis factor-alpha gene promoter region alter the risk of psoriasis vulgaris and psoriatic arthritis: a meta-analysis.A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activationAssociations between tumor necrosis factor-α polymorphisms and risk of psoriasis: a meta-analysis.A pilot study of the association of tumor necrosis factor alpha polymorphisms with psoriatic arthritis in the Romanian population.Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritisGenetic screening test for psoriatic arthritis and UVB irradiation potential responders: A new tool to identify psoriasis subpopulation patients?The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiencyPsoriasis and psoriatic arthritis: separate or one and the same?Psoriatic arthritis: genetic susceptibility and pharmacogenetics.Genetics of psoriasis and psoriatic arthritis: update and future direction.Psoriatic arthritis in Asia.Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program.Genetics of susceptibility and treatment response in psoriatic arthritis.Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases.Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk.TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients.Ustekinumab for the treatment of psoriatic arthritis.Effect of tumor necrosis factor-α inhibitors on ambulatory 24-h blood pressure.Influence of TNF and IL17 Gene Polymorphisms on the Spondyloarthritis Immunopathogenesis, Regardless of HLA-B27, in a Brazilian Population.
P2860
Q27693878-4E9FD63F-6AF2-45D7-B590-057FD75DC719Q28069849-2D7A03B2-2A82-4538-832B-5AA5DD080E29Q28222837-D30A1313-C1CF-4354-9BCD-A07EE9E83EBDQ28288855-624E0B3B-5ACE-4FB5-B7C8-097C6B67BE74Q33920406-128B43CA-7973-4141-8C06-E049EFEDB153Q34533598-8810829C-A13E-4901-98E0-C34878ACFBB5Q34745794-C2D7DE24-8B62-4EDD-A8A5-2EFA430165BCQ34999751-B6AA1163-E462-4E95-8CDD-5414F9D20CABQ35063651-95BA30D3-20D0-4B6B-9605-9D19A0C58337Q35229490-8B06FE67-AF5A-41E6-B5E0-21F329F715F7Q35694939-85F41276-BCBF-4DFA-A3CF-A1B0CFF8DFBAQ36349330-9AC37234-219D-4E0A-9A35-FE7B6019F186Q36782392-96BD3BF7-6A4D-4EF6-8826-2FDE8AE7D219Q36921661-8A841713-F3B6-4930-BA3D-BE72510DD8CFQ37120837-8974BA44-F30D-487D-9016-5C94A561663EQ37210204-E7CC9715-97E1-425B-97F9-2E082DF84871Q37588346-BBE85BD8-8699-441D-88EC-E7E078538211Q37778661-FB5F45D5-FEE4-4C40-9B19-59E5F5DCE260Q37953810-E5B44C1F-987E-47ED-86FD-66237A59E119Q38075774-9DA022EC-9FF6-47C7-B3D5-874388D5FB73Q38177340-D4152ABF-C600-4659-B8F0-82C55DD30801Q41333257-510113B1-0144-41AE-8558-9ACA86F68285Q48086737-178ED306-62A3-4188-9234-C1A0AA78CF21Q51329120-40E761B2-C2E8-421F-B65A-BB5FF1271D32Q54966906-BD6867E1-3CDC-44C0-9284-443E311510B4
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
TNFalpha polymorphisms and risk of psoriatic arthritis.
@ast
TNFalpha polymorphisms and risk of psoriatic arthritis.
@en
type
label
TNFalpha polymorphisms and risk of psoriatic arthritis.
@ast
TNFalpha polymorphisms and risk of psoriatic arthritis.
@en
prefLabel
TNFalpha polymorphisms and risk of psoriatic arthritis.
@ast
TNFalpha polymorphisms and risk of psoriatic arthritis.
@en
P2093
P2860
P356
P1476
TNFalpha polymorphisms and risk of psoriatic arthritis.
@en
P2093
P2860
P304
P356
10.1136/ARD.2005.039164
P407
P577
2005-11-10T00:00:00Z